Prescribing in COVID-19 patients: Should we take into account inflammation?
作者信息
Marzolini Catia, Battegay Manuel, Sendi Parham, Back David J
机构信息
Division of Infectious Diseases and Hospital Epidemiology, University Hospital Basel and University of Basel, Basel, Switzerland.
Department of Molecular and Clinical Pharmacology, Institute of Translational Medicine, University of Liverpool, Liverpool, UK.
出版信息
Br J Clin Pharmacol. 2021 Mar;87(3):719-721. doi: 10.1111/bcp.14524. Epub 2020 Aug 20.
PMID:32820554
Abstract
摘要
相似文献
1
Prescribing in COVID-19 patients: Should we take into account inflammation?为新冠肺炎患者开处方时：我们应该考虑炎症因素吗？
Br J Clin Pharmacol. 2021 Mar;87(3):719-721. doi: 10.1111/bcp.14524. Epub 2020 Aug 20.
2
Disease-drug and drug-drug interaction in COVID-19: Risk and assessment.2019冠状病毒病中的疾病-药物及药物-药物相互作用：风险与评估
Biomed Pharmacother. 2021 Jul;139:111642. doi: 10.1016/j.biopha.2021.111642. Epub 2021 Apr 27.
3
Familial hemophagocytic lymphohistiocytosis induced by SARS-CoV-2.由严重急性呼吸综合征冠状病毒2（SARS-CoV-2）引起的家族性噬血细胞性淋巴组织细胞增生症
Pediatr Hematol Oncol. 2021 May;38(4):406-409. doi: 10.1080/08880018.2020.1867267. Epub 2021 Feb 26.
4
Berberine reduces circulating inflammatory mediators in patients with severe COVID-19.黄连素可降低重症 COVID-19 患者循环中的炎症介质水平。
Br J Surg. 2021 Jan 27;108(1):e9-e11. doi: 10.1093/bjs/znaa021.
5
Use of Remdesivir in Myasthenia gravis and COVID-19.使用瑞德西韦治疗重症肌无力和 COVID-19。
Pharmacotherapy. 2021 Jun;41(6):546-550. doi: 10.1002/phar.2524. Epub 2021 Apr 27.
6
Hyper-inflammatory responses in COVID-19 and anti-inflammatory therapeutic approaches.COVID-19 中的过度炎症反应和抗炎治疗方法。
BMB Rep. 2022 Jan;55(1):11-19. doi: 10.5483/BMBRep.2022.55.1.152.
7
An Example of Employing the Principles of Bioethics to Medical Decision Making in the COVID-19 Era.在新冠疫情时代将生物伦理原则应用于医疗决策的一个实例。
Laryngoscope. 2020 Nov;130(11):2688-2689. doi: 10.1002/lary.28896. Epub 2020 Aug 13.
8
Prescribing COVID-19 treatments: what we should never forget.开具新冠治疗药物：我们绝不能忘记的事。
J Infect. 2020 Aug;81(2):e85. doi: 10.1016/j.jinf.2020.05.018. Epub 2020 May 13.
9
Cepharanthine: a review of the antiviral potential of a Japanese-approved alopecia drug in COVID-19.盐酸塞拉嗪：一种已获日本批准的脱发药物在 COVID-19 中的抗病毒潜力综述。
Pharmacol Rep. 2020 Dec;72(6):1509-1516. doi: 10.1007/s43440-020-00132-z. Epub 2020 Jul 22.
10
Antiviral and Anti-Inflammatory Properties of Ivermectin and Its Potential Use in COVID-19.伊维菌素的抗病毒和抗炎特性及其在COVID-19中的潜在用途
Arch Bronconeumol (Engl Ed). 2020 Dec;56(12):831. doi: 10.1016/j.arbres.2020.06.011. Epub 2020 Jul 7.
Zotero 插件